Haytham Tlayjeh

1.9k total citations
19 papers, 397 citations indexed

About

Haytham Tlayjeh is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Haytham Tlayjeh has authored 19 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 5 papers in Neurology and 5 papers in Epidemiology. Recurrent topics in Haytham Tlayjeh's work include COVID-19 Clinical Research Studies (11 papers), Sepsis Diagnosis and Treatment (5 papers) and Long-Term Effects of COVID-19 (5 papers). Haytham Tlayjeh is often cited by papers focused on COVID-19 Clinical Research Studies (11 papers), Sepsis Diagnosis and Treatment (5 papers) and Long-Term Effects of COVID-19 (5 papers). Haytham Tlayjeh collaborates with scholars based in Saudi Arabia, United States and Canada. Haytham Tlayjeh's co-authors include Imad M. Tleyjeh, Tarek Kashour, Muhammad Riaz, Zakariya Kashour, Leslie C. Hassett, M. Rizwan Sohail, Dana Gerberi, Musa A. Garbati, Mohamad Al‐Tannir and Moussab Damlaj and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Critical Care Medicine.

In The Last Decade

Haytham Tlayjeh

18 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haytham Tlayjeh Saudi Arabia 9 276 163 51 40 36 19 397
Zakariya Kashour Canada 8 245 0.9× 143 0.9× 45 0.9× 30 0.8× 21 0.6× 8 342
Anant Parasher India 4 280 1.0× 159 1.0× 40 0.8× 46 1.1× 49 1.4× 14 502
Vijairam Selvaraj United States 12 242 0.9× 122 0.7× 50 1.0× 32 0.8× 66 1.8× 45 440
Simone Bastrup Israelsen Denmark 14 170 0.6× 79 0.5× 114 2.2× 58 1.4× 30 0.8× 31 452
Pramath Kakodkar Ireland 7 226 0.8× 102 0.6× 44 0.9× 43 1.1× 29 0.8× 22 463
Anupam Sule United States 9 338 1.2× 134 0.8× 47 0.9× 56 1.4× 29 0.8× 41 534
Lianfeng Lu China 8 554 2.0× 260 1.6× 85 1.7× 97 2.4× 47 1.3× 21 758
Sujan Badal United States 5 226 0.8× 91 0.6× 46 0.9× 90 2.3× 30 0.8× 6 427
Ashan Pan China 3 566 2.1× 272 1.7× 60 1.2× 131 3.3× 54 1.5× 6 717
Martín Ragusa Argentina 7 389 1.4× 168 1.0× 110 2.2× 142 3.5× 38 1.1× 19 575

Countries citing papers authored by Haytham Tlayjeh

Since Specialization
Citations

This map shows the geographic impact of Haytham Tlayjeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haytham Tlayjeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haytham Tlayjeh more than expected).

Fields of papers citing papers by Haytham Tlayjeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haytham Tlayjeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haytham Tlayjeh. The network helps show where Haytham Tlayjeh may publish in the future.

Co-authorship network of co-authors of Haytham Tlayjeh

This figure shows the co-authorship network connecting the top 25 collaborators of Haytham Tlayjeh. A scholar is included among the top collaborators of Haytham Tlayjeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haytham Tlayjeh. Haytham Tlayjeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Damlaj, Moussab, et al.. (2021). Reducing Futile Acute Care Services for Terminally Ill Patients With Cancer: The Dignity Project. JCO Oncology Practice. 17(11). e1794–e1802. 6 indexed citations
3.
Kashour, Tarek, Aref A. Bin Abdulhak, Haytham Tlayjeh, et al.. (2020). Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Mortality Among COVID-19 Patients: A Systematic Review and Meta-Analysis. American Journal of Therapeutics. 30(4). e336–e346. 5 indexed citations
4.
Kashour, Zakariya, Muhammad Riaz, Musa A. Garbati, et al.. (2020). Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy. 76(1). 30–42. 95 indexed citations
5.
Tleyjeh, Imad M., Zakariya Kashour, Moussab Damlaj, et al.. (2020). Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis. Clinical Microbiology and Infection. 27(2). 215–227. 127 indexed citations
6.
Tlayjeh, Haytham, Mushira A. Enani, Lukman Thalib, et al.. (2020). Association of corticosteroids use and outcomes in COVID-19 patients: A systematic review and meta-analysis. Journal of Infection and Public Health. 13(11). 1652–1663. 48 indexed citations
7.
Tleyjeh, Imad M., Aref A. Bin Abdulhak, Haytham Tlayjeh, et al.. (2020). Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and the Risk of SARS-CoV-2 Infection or Hospitalization With COVID-19 Disease: A Systematic Review and Meta-Analysis. American Journal of Therapeutics. 29(1). e74–e84. 4 indexed citations
8.
Tleyjeh, Imad M., Zakariya Kashour, Muhammad Riaz, et al.. (2020). Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis. SHILAP Revista de lepidopterología. 5(1). 137–150. 43 indexed citations
9.
Tlayjeh, Haytham, Mushira A. Enani, Lukman Thalib, et al.. (2020). Efficacy of Corticosteroids in COVID-19 Patients: A Systematic Review and Meta-Analysis. medRxiv. 1 indexed citations
10.
Damlaj, Moussab, et al.. (2020). Reducing futile acute care services (ACS) for terminally ill cancer patients (Dignity Project).. Journal of Clinical Oncology. 38(29_suppl). 23–23. 2 indexed citations
11.
Kashour, Zakariya, Muhammad Riaz, Musa A. Garbati, et al.. (2020). Efficacy of Chloroquine or Hydroxychloroquine in COVID-19 Patients: A Systematic Review and Meta-Analysis. medRxiv. 11 indexed citations
12.
Tleyjeh, Imad M., Zakariya Kashour, Muhammad Riaz, et al.. (2020). The Cardiac Toxicity of Chloroquine or Hydroxychloroquine in COVID-19 Patients: A Systematic Review and Meta-regression Analysis. medRxiv. 11 indexed citations
13.
Abdulhak, Aref A. Bin, Tarek Kashour, Haytham Tlayjeh, et al.. (2020). Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcome of COVID-19 : A Systematic Review and Meta-analysis. medRxiv. 9 indexed citations
14.
Tlayjeh, Haytham, Yaseen M. Arabi, Niall D. Ferguson, et al.. (2019). Body Mass Index and Mortality in Subjects With ARDS: Post-hoc Analysis of the OSCILLATE Trial. Respiratory Care. 64(9). 1042–1048. 10 indexed citations
15.
Arabi, Yaseen M., Musharaf Sadat, Hani Tamim, et al.. (2019). 1608: OUTCOMES OF ICU PATIENTS WITH SEPSIS AND SEPTIC SHOCK IN SAUDI ARABIA OVER A 16-YEAR PERIOD. Critical Care Medicine. 48(1). 780–780. 1 indexed citations
16.
Al‐Dorzi, Hasan M., et al.. (2017). Characteristics and predictors of mortality of patients with hematologic malignancies requiring invasive mechanical ventilation. Annals of Thoracic Medicine. 12(4). 259–259. 17 indexed citations
17.
Harbi, Shmeylan Al, et al.. (2013). The association between statin therapy during intensive care unit stay and the incidence of venous thromboembolism: a propensity score-adjusted analysis. BMC Pharmacology and Toxicology. 14(1). 57–57. 5 indexed citations
18.
Arabi, Yaseen M., et al.. (2010). Analysis Of Incident Reports In A Tertiary Care Center. A2403–A2403. 1 indexed citations
19.
Tlayjeh, Haytham, Yaseen M. Arabi, Hasan M. Al‐Dorzi, et al.. (2010). Assessment Of Critical Care Physicians Using A Subjective Global Rating Scale Of The ACGME Competencies Versus A Simulation Based Crisis Resource Management Scale. A1663–A1663. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026